You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A survey asking researchers for their thoughts on the key developments in the field turned up applications ranging from clinical to structural.
As 2020 dawns, forensic genomics is poised for growth as companies aim to harness the power of consumer databases coupled with advances in sequencing.
The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.
Researchers in the US and the United Arab Emirates found that RNA-seq in B-lymphoblastoid cell lines can help identify pathogenic variants that DNA testing missed.
Researchers in academia and industry are showing interest in the scale offered by Inscripta's Onyx platform for genome editing, launched in October.
The firm, Universal Sequencing Technology, recently launched a library prep kit to get long-range information from short reads and is working on a long-read sequencing platform.
With new instruments and workflows able to quantify thousands of proteins in as little as five minutes, 2019 was the year proteomics cracked its throughput problem.
Despite the availability of more precision therapies and complex biomarker tests, systemic gaps and lack of physician education continued to hinder access.
Run by the Simons Foundation Autism Research Initiative, SPARK has already grown to more than 220,000 participants from 75,000 families living in the US.
Researchers from France's DreamPore and their collaborators used a nanopore to distinguish between 15 of the 20 proteinogenic amino acids.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.